Business Description
Nanjing Medlander Medical Technology Co Ltd
ISIN : CNE100005PV8
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 58.57 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.13 | |||||
Interest Coverage | 122.99 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 10.7 | |||||
Beneish M-Score | -1.97 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -8.8 | |||||
3-Year EBITDA Growth Rate | -14.9 | |||||
3-Year EPS without NRI Growth Rate | -24 | |||||
3-Year FCF Growth Rate | -23.9 | |||||
3-Year Book Growth Rate | 61 | |||||
Future 3-5Y EPS without NRI Growth Rate | 47.43 | |||||
Future 3-5Y Total Revenue Growth Rate | 26.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 28.74 | |||||
9-Day RSI | 35.51 | |||||
14-Day RSI | 40.85 | |||||
6-1 Month Momentum % | 21.62 | |||||
12-1 Month Momentum % | -22.44 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 8.04 | |||||
Quick Ratio | 7.57 | |||||
Cash Ratio | 7.23 | |||||
Days Inventory | 187.51 | |||||
Days Sales Outstanding | 15.75 | |||||
Days Payable | 62.91 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 4.19 | |||||
Dividend Payout Ratio | 0.58 | |||||
Forward Dividend Yield % | 4.19 | |||||
5-Year Yield-on-Cost % | 4.19 | |||||
3-Year Average Share Buyback Ratio | -10.3 | |||||
Shareholder Yield % | 3.7 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 72.62 | |||||
Operating Margin % | 26.83 | |||||
Net Margin % | 26.55 | |||||
FCF Margin % | -2.83 | |||||
ROE % | 7.51 | |||||
ROA % | 6.62 | |||||
ROIC % | 20.04 | |||||
ROC (Joel Greenblatt) % | 49.9 | |||||
ROCE % | 8.35 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 23.57 | |||||
Forward PE Ratio | 12.68 | |||||
PE Ratio without NRI | 23.5 | |||||
PS Ratio | 6.3 | |||||
PB Ratio | 1.85 | |||||
Price-to-Tangible-Book | 2.02 | |||||
Price-to-Operating-Cash-Flow | 20.53 | |||||
EV-to-EBIT | 13.77 | |||||
EV-to-EBITDA | 13.77 | |||||
EV-to-Revenue | 4.26 | |||||
EV-to-FCF | -155.43 | |||||
Price-to-Graham-Number | 1.44 | |||||
Price-to-Net-Current-Asset-Value | 2.93 | |||||
Price-to-Net-Cash | 3.36 | |||||
Earnings Yield (Greenblatt) % | 7.26 | |||||
FCF Yield % | -0.45 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Nanjing Medlander Medical Technology Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 380.947 | ||
EPS (TTM) (Â¥) | 1.027 | ||
Beta | 0 | ||
Volatility % | 46.38 | ||
14-Day RSI | 40.85 | ||
14-Day ATR (Â¥) | 0.937238 | ||
20-Day SMA (Â¥) | 25.533 | ||
12-1 Month Momentum % | -22.44 | ||
52-Week Range (Â¥) | 17.64 - 33.57 | ||
Shares Outstanding (Mil) | 100 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Nanjing Medlander Medical Technology Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Nanjing Medlander Medical Technology Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Nanjing Medlander Medical Technology Co Ltd Frequently Asked Questions
What is Nanjing Medlander Medical Technology Co Ltd(SHSE:688273)'s stock price today?
When is next earnings date of Nanjing Medlander Medical Technology Co Ltd(SHSE:688273)?
Does Nanjing Medlander Medical Technology Co Ltd(SHSE:688273) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |